Rockpool Investments

About Rockpool Investments

Rockpool Investments LLP is a London-headquartered direct-investment private equity and private debt platform founded in 2011 by partners with prior 3i and Bridgepoint experience. The firm operates as an FCA-regulated LLP. Rather than raising traditional closed-end fund vehicles from institutional LPs, Rockpool runs a deal-by-deal syndication model matching high-net-worth individuals and family offices with growth-stage UK private companies through tax-efficient wrappers including the Enterprise Investment Scheme, the Rockpool IFISA and the Rockpool SIPP. Since inception the firm has deployed over GBP 745 million (approximately €870 million) into more than 150 UK private companies. The platform operates four core service strategies: growth equity, private debt, the Rockpool IFISA and the Rockpool SIPP. Rockpool was named Private Equity House of the Year (Small-Cap) at the 2025 Real Deals Private Equity Awards following eight successful exits in the preceding three years.

Investment thesis

Rockpool Investments pursues a sector-neutral UK-only lower mid-market strategy targeting profitable and growing private businesses with strong management teams. The growth-equity arm provides expansion capital, MBO finance and replacement-capital solutions, while the private-debt arm offers structured loans with interest in the 10 to 12 percent range plus equity-linked upside targeting blended portfolio returns of 15 percent per annum across interest and growth. Sector activity spans business services, manufacturing, healthcare, education, consumer services, e-commerce, energy services, financial services, internet software and services and distribution. Geography is exclusively the United Kingdom with a bias toward profitable companies headquartered outside London. The investor base comprises direct individual investors and intermediated wealth-management clients deploying through EIS-qualifying syndicated structures, the IFISA wrapper, the SIPP wrapper and discretionary private-company portfolios. The firm targets approximately GBP 60 million of deployment annually across roughly six to ten platform deals plus follow-ons, with observable transactions clustering in the GBP 3 to GBP 15 million range. Value creation centres on hands-on board engagement, professionalisation of finance and reporting functions, buy-and-build M&A support and active preparation for trade-sale or secondary exits.

Recent activity

Recent investments include TalarMade in healthcare and medical devices (2025), Imperial Corporate Events in events and travel services (2025), CareScribe in assistive technology and EdTech (2025), Harley Academy in healthcare training (2024) and Oxford Online Pharmacy in healthcare (2024). Recent exits include Hydralectric in manufacturing (2025), MomentumABM in professional services (2025), Mecsia in business services (2024), Smyle in marketing and events (2024) and Alchemist Learning and Development in training and professional services (2024). The platform continues to deploy across UK lower mid-market growth equity and private debt through EIS, IFISA and SIPP wrappers. Detailed buyer names and multiple data available on Pro at €29/month.